Segment-specific c-ErbB2 expression in human autosomal recessive polycystic kidney disease

被引:0
|
作者
Nakanishi, K
Sweeney, WE
Avner, ED
机构
[1] Rainbow Babies & Childrens Hosp, Dept Pediat, Rainbow Ctr Childhood PKD, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Cleveland, OH 44106 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
c-ErbB2 (also referred to as Neu or HER2), a transmembrane glycoprotein with intrinsic tyrosine kinase activity, is structurally related to epidermal growth factor receptor (EGFR) and forms active heterodimers with EGFR as well as other members of the EGFR family. c-ErbB2 is reported to mediate differentiation and proliferation in epithelial cells and is expressed in a tissue-specific and developmental stage-specific manner. Given the role of EGFR in cystic renal epithelial hyperplasia and the immature phenotype of cystic renal epithelial cells, the segment-specific expression pattern of c-ErbB2 in human autosomal recessive polycystic kidney disease (ARPKD) was examined in nine ARPKD kidney specimens ranging from gestational age 17 wk through postnatal age 4 wk. c-ErbB2 staining of human ARPKD samples showed increased expression with increasing gestational age compared with normal human fetal and postnatal kidneys. This increased c-ErbB2 expression was primarily localized to the apical surfaces of cystic collecting tubule cells, similar to the pattern of EGFR expression, and paralleled collecting tubular cyst formation and growth.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 50 条
  • [41] AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY-DISEASE (ARPCKD)
    KAPLAN, BS
    FAY, J
    SHAH, V
    DILLON, MJ
    BARRATT, TM
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1987, 10 (04): : A66 - A66
  • [42] Molecular genetics of autosomal recessive polycystic kidney disease
    Harris, PC
    Rossetti, S
    MOLECULAR GENETICS AND METABOLISM, 2004, 81 (02) : 75 - 85
  • [43] Autosomal Recessive Polycystic Kidney Disease: Not just a Renal Disease
    Rohatgi, Sarika
    Sweeney, William E.
    Schwasinger, Emma
    Kampa, Nicholas
    Avner, Ellis D.
    HEPATOLOGY, 2015, 62 : 1046A - 1046A
  • [44] Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease
    Lilova, M
    Kaplan, BS
    Meyers, KEC
    PEDIATRIC NEPHROLOGY, 2003, 18 (01) : 57 - 61
  • [45] Proximal tubular cysts in fetal human autosomal recessive polycystic kidney disease
    Nakanishi, K
    Sweeney, WE
    Zerres, K
    Guay-Woodford, LM
    Avner, ED
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2000, 11 (04): : 760 - 763
  • [46] The mTOR Pathway Is Activated in Human Autosomal-Recessive Polycystic Kidney Disease
    Becker, Jan Ulrich
    Saez, Anabelle Opazo
    Zerres, Klaus
    Witzke, Oliver
    Hoyer, Peter Friedrich
    Schmid, Kurt Werner
    Kribben, Andreas
    Bergmann, Carsten
    Nuernberger, Jens
    KIDNEY & BLOOD PRESSURE RESEARCH, 2010, 33 (02): : 129 - 138
  • [47] Recombinant human growth hormone therapy in autosomal recessive polycystic kidney disease
    Marusia Lilova
    Bernard S. Kaplan
    Kevin E. C. Meyers
    Pediatric Nephrology, 2003, 18 : 57 - 61
  • [48] Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease
    Loghman-Adham, M
    Soto, CE
    Inagami, T
    Sotelo-Avila, C
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2005, 53 (08) : 979 - 988
  • [49] The Pckcr Rat Model of Autosomal Recessive Polycystic Kidney Disease
    Gattone, Vincent H.
    Sinders, Rachel
    Roberts, Robin
    Owens, Dwight R.
    FASEB JOURNAL, 2008, 22
  • [50] Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases
    Torres, VE
    Harris, PC
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (01): : 40 - 55